# DECITABINE
> **ANDA212117** · Abbreviated New Drug Application (Generic) · Sponsor: NIVAGEN PHARMS INC · Approved 2020-12-07
## Drug
- **FDA Application Number:** ANDA212117
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DECITABINE
- **Generic name:** DECITABINE
- **Active ingredients:** DECITABINE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** NIVAGEN PHARMS INC
- **Manufacturer:** Nivagen Pharmaceuticals, Inc.
- **First approval:** 2020-12-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212117)
---
*AI Analytics · CC0 1.0*